• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

Animal & Veterinary

  • Print
  • Share
  • E-mail

New Animal Drug Approvals - July/August 2004

FDA Veterinarian Newsletter July/August 2004 Volume XIX, No IV

Company
Generic and (Brand) Names
Indications
Routes/Remarks

Boehringer Ingelheim Vetmedica, Inc.
(NADA 141-228)
N-butylscopolammonium bromide (Buscopan Injectable Solution)
Horses. For the control of abdominal pain (colic) associated with spasmodic colic, flatulent colic and simple impactions in horses.
INJECTABLE—The NADA provides for the veterinary prescription use of a solution of N-butylscopolammonium bromide by intravenous injection for the control of abdominal pain (colic) associated with spasmodic colic, flatulent colic, and simple impactions in horses.
Federal Register 06/25/04

Intervet, Inc.
(NADA 141-236)
Porcine zinc insulin (Vetsulin Suspension)
Dogs. For the reduction of hyperglycemia and hyperglycemia-associated clinical signs in dogs with diabetes mellitus.
INJECTABLE—The NADA provides for the veterinary prescription use of an injectable suspension of zinc insulin of porcine origin for the reduction of hyperglycemia and hyperglycemia-associated clinical signs in dogs with diabetes mellitus.
Federal Register 05/10/04